Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma

Allergol Int. 2024 Apr 5:S1323-8930(24)00043-1. doi: 10.1016/j.alit.2024.03.005. Online ahead of print.

Affiliations

¹ Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
² Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan. Electronic address: mmatsuyama@md.tsukuba.ac.jp.
³ Department of Genome Biology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.

PMID: 38582716
DOI: 10.1016/j.alit.2024.03.005

No abstract available

Publication types

Letter